RIBOCICLIB for Hormone receptor positive her2 negative breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 2,343 adverse event reports in the FDA FAERS database where RIBOCICLIB was used for Hormone receptor positive her2 negative breast cancer.
Most Reported Side Effects for RIBOCICLIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Neutropenia | 3,585 | 12.8% | 191 | 621 |
| Nausea | 3,404 | 12.2% | 362 | 1,113 |
| Fatigue | 3,327 | 11.9% | 320 | 900 |
| Malignant neoplasm progression | 2,468 | 8.8% | 683 | 585 |
| Death | 2,452 | 8.8% | 2,447 | 356 |
| Vomiting | 1,953 | 7.0% | 325 | 869 |
| Diarrhoea | 1,830 | 6.5% | 164 | 651 |
| White blood cell count decreased | 1,683 | 6.0% | 110 | 377 |
| Pain | 1,637 | 5.9% | 213 | 633 |
| Metastases to bone | 1,538 | 5.5% | 148 | 321 |
| Dyspnoea | 1,473 | 5.3% | 323 | 760 |
| Breast cancer metastatic | 1,450 | 5.2% | 488 | 395 |
| Malaise | 1,434 | 5.1% | 179 | 592 |
| Asthenia | 1,416 | 5.1% | 205 | 550 |
| Anaemia | 1,387 | 5.0% | 221 | 617 |
Other Indications for RIBOCICLIB
Breast cancer metastatic (9,771)
Breast cancer (6,953)
Product used for unknown indication (6,658)
Breast cancer female (744)
Metastases to bone (383)
Her2 negative breast cancer (247)
Breast cancer stage iv (186)
Invasive ductal breast carcinoma (178)
Neoplasm malignant (171)
Metastases to liver (154)
Other Drugs Used for Hormone receptor positive her2 negative breast cancer
LETROZOLE (1,106)
FULVESTRANT (823)
PALBOCICLIB (386)
ABEMACICLIB (220)
ANASTROZOLE (187)
ALPELISIB (171)
PACLITAXEL (92)
EXEMESTANE (86)
CYCLOPHOSPHAMIDE (83)
SACITUZUMAB GOVITECAN-HZIY (81)